Moreover, the studies by Bai et al. and Wang et al. detected the presence of GPNMB in the cortex, CSF, and serum of AD patients using a multimodal proteomic method, with the elevated CSF levels confirmed by an alternative method (ELISA) [41,42]. This evidence concerns the gene GPNMB and Alzheimer disease.